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ABSTRAK
Latar Belakang: Prosedur embrio vitrifikasi menggunakan alat berupa grid, straw atau cryoloop. Gama Sleeved
cryoloop dibuat dan dikembangkan di klinik Permata Hati. Untuk itu, dilakukan pengamatan keberhasilan prosedur
vitrifikasi menggunakan 0.1µl Gama Sleeved cryoloop.
Metode: Vitrifikasi dilakukan pada blastokis dengan kualitas baik yang diperoleh pada hari ke 5 setelah fertilisasi.
Inform consent telah disampaikan sebelumnya kepada pasien program bayi tabung di Klinik Permata Hati. Prosedur
dilakukan dengan menggunakan media handling (GMOPS Plus; Vitrolife) embrio diinkubasi selama 1 menit; (7.5%
EG (v/v); 7.5% DMSO (v/v)) selama 2-3 menit,  (15% EG (v/v); 15% DMSO v/v; 10 mg/ml Ficoll; 0.65 M Sucrosa)
selama 30 detik pada suhu ruang sebelum kemudian diletakkan di dalam cryoloop, setelah itu secara cepat
cryoloop yang berisi embrio dibenamkan ke dalam nitrogen cair.  Sebelum dilakukan embryo transfer (ET), embrio
dihangatkan dengan cara two step technique (sucrose 0.25M) selama 2 menit dan  selama 3 menit (sucrose
0.125M).
Hasil: Sejumlah 97 blastokis divitrifikasi dan dihangatkan (67 pasien), dimana 91 blastokis berhasil ditransfer ke
rahim ibu (93.8%). Blastokis yang tidak berhasil selamat dari prosedur penghangatan adalah blastokis dengan
kerusakan lebih dari 50%. Diperoleh kehamilan klinis 43.3% sedangkan angka implantasi adalah 37.4%. Sampai
saat ini, dilaporkan 20 kelahiran (23 bayi) dari program vitrifikasi menggunakan 0.1µl Gama Sleeved cryoloop,
sementara 5 kehamilan masih berlangsung. Satu kehamilan dilaporkan gugur pada usia kehamilan yang masih
sangat awal, dua keguguran pada usia kehamilan 12 minggu dan satu bayi lahir meninggal karena kelainan
kongenital.
Kesimpulan: 0.1µl Gama Sleeved cryoloop merupakan pilihan untuk digunakan sebagai alat vitrifikasi blastokis.
Data awal yang kami sampaikan dan kelahiran bayi dari program tersebut memberikan harapan untuk kesuksesan
program simpan beku embrio di klinik Permata Hati RSUP DR Sardjito Yogyakarta.
Kata kunci: kriopreservasi, blastokis, vitrifikasi
ABSTRACT
Background: Vitrification has been applied succesfully in human embryo using grid, straw and cryoloop. Gama
Sleeved is a home made device develop at Permata Hati. We assessed the survival rate of human blastocyst
vitrified in 0.1µl Gama Sleeved cryoloop as device.
Method: Excess good grade human D5 embryos were vitrified, upon a detailed informed consent. Embryos were
hold in handling media (GMOPS Plus; Vitrolife) for 1 minute; (7.5% EG (v/v); 7.5% DMSO (v/v)) for 2-3 minutes,  (15%
EG (v/v); 15% DMSO v/v; 10 mg/ml Ficoll; 0.65 M Sucrosa) for 30 seconds  at room temperature before inserted in
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to the loops, then directly plunged into the liquid nitrogen. Prior to ET, embryos were warmed by two step technique
in sucrose 0.25M for 2 min and 0.125M sucrosa for 3 min. Embryos were then cultured.
Results: Total of 97 vitrified warmed human blastocyst (67 patients) were used and 91 (93.8%) were transferred.
Non-transferred blastocyst (6.2%) has more than 50% lyse. The clinical pregnancy rate was  43.9%. The implantation
rate was 37.4%. Currently, 20 deliveries of 23 babies born from vitrified blastocyst using 0.1µl Gama Sleeved
cryoloop, and another 5 ongoing pregnancy. So far there was 1 early pregnancy loss, 2 miscarriages at 12 weeks
pregnancy, and one infant died due to a congenital anomaly.
Conclusion: 0.1µl Gama Sleeved cryoloop provides an excellent alternative to existing vitrification devices. These
initial data and babies delivered from the program have been promising to a vitrification system in our own ART
program.
Keywords: cryopreservation, blastocyst, vitrification
INTRODUCTION
The development of ovarian hyperstimulation
protocols and culture system by sequential media
has proven to improve pregnancy rates in ART and
the number of embryos produced.1 Consequence of
increased number of transfering embryo will be high
incidence of multiple gestation. Therefore, it has
been proposed necessarily to limit the number of
embryos to be transferred.2,3  Transfering a single
embryo or two would reduce the incidence of
multiple gestations while maintaining the pregnancy
rates4. Extended culture to blastocyst stage seems
to be a usefull aproach since developmental arrest
are frequently occur at earlier stages.1,5
In a situation of OHSS (Ovarian Hyper Stimulation
Syndrome) or when there is an extreme difficulties
in embryo replacement procedure, embryo
cryopreservation would be an advantage. When a
problem occurs, the embryos will be preserved. They
can then be transferred in an elective cycle.
Slow freezing remains the most commonly used
method for embryo preservation in ART laboratories
around the world, but many studies have recently
reported an increasing success of clinical results with
vitrification.6,7,8,9
Important factor in achieving optimal result of
vitrification procedures is cryoprotective agents
(CPA).10,11,12 Cryoprotectants are essential for the
cryopreservation of cells. During vitrification, there
is a practical limit of the procedures to attain cooling
speed, and a biological limit of the cells on the
concentration of cryoprotectant tolerated by cells. A
critical concentration of cryoprotectant is required
for vitrification. Variation in concentration can lead
to either osmotic or chemical toxicity. Balance
between maximizing the cooling rate and minimizing
the cryoprotective concentration is important.
Another important factor to improve outcomes
is device in order to accommodate embryos in such a
way that the embryos will not lose and sustain their
viability. Types of devices used for vitrification,
including in human services application, there are
hemi-straw, open pulled straw, microscopic grid,
cryotop and cryoloop that have been investigated to
increase the cooling and warming speed; thus, the
CPA concentration can be reduced up to 25-35%.7,6,13,14
This present study reported our initial clinical
data as well as live birth rate outcomes , with the
0.1µl Gama Sleeved cryoloop.  The efficacy of the
divice to preserve embryo at the blastocyst stage was
analyzed following frozen embryo transfer (FET)
program at Permata Hati Infertility Clinic-RSUP DR
Sardjito.
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METHOD
Blastocyst culture
Patients administerred for IVF program in our
infertility clinic were agreed to vitrified some of their
viable blastocyst upon completion of inform consent.
All couples participating in the study signed and
approved consent form prior to the method
application. The mean age of the women was 33.1
years and range was from 28-39 years old.
Women were treated with GnRH agonist and
hMG in either a long- or a short-treatment protocol.
Oocytes were collected 36 hours after hCG
administration using the vaginal ultrasound-guided
procedure. The oocytes were inseminated by either
conventional IVF or intracytoplasmic sperm
injection. Fertilization was assessed 16-18 hours after
insemination. Embryos having two pronuclei were
washed well and cultured in groups of two to three
in G1-Plus media (Vitrolife, Gothenburg, Sweden)
in an atmosphere of 6% CO2, 5% O2, and 89% N2.
After 48 hours of culture in G1-Plus, embryos were
selected for embryo transfer procedure. Excess
embryos were rinsed three times and transferred
into G2-Plus  medium (Vitrolife, Gothenburg,
Sweden) for further 48–72 hours culture. On day 5 or
day 6, embryos were assessed for their development
into blastocysts. Good grade blastocysts were vitrified
with the Gama Sleeved cryoloop.
Cryoloop
Gama Sleeved is a home made cryoloop. Handle
of the cryoloop is made from the handle of 1 mL
syringe, mechanically formed to accomodate
handling and identification of the loop. Loop
mounted to the stainless tube of 1 mL syringe covered
by sleeved of 0.5 cryostraw. The diameter of the cover
sleeved, which is just bigger than handle cryostraw
allowing fixation of the sleeve on the handle
cryostraw. The sleeved aimed to elude contamination
that may occur in the cryo tank environment. The
sleeved cryoloop then dipped in to the goblet in the
liquid nitrogen.
Considering convenience of the handling
procedure, total length of the sleeved cryo-loop is
12 cm. The handling part of the cryo-loop is 8.5 cm in
length and it consist of fiber resistible to ultralow
temperature environment of liquid nitrogen that is -
196°C. Stainless mounted to the edge of the handling
fiber will support confidently the loop that is made
from 10.0 needle (Ethycon). The loop diameter is 700-
800µm and mechanically pressed to fix to the
stainless. Loop will be covered by transparent 7 cm
length sleeved made from 0.5 ml cryostraw (Cassou
Straw, IMV, France) allowing observation the embryos
in the loop easily. Figure 1. is showing embryo that is
put in the thin layer of CPA in the loop.
Figure 1. Loop filled by 0.1-0,2 µl CPA (A); Embryo sit on the thin CPA layer (arrow)(B) (Ita Fauzia, 2014,
Dissecting stereo Microscope, 40X, Olympus); Gama Sleeved cryoloop (C)
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Figure 2 illustrates the morphology of blastocyst
in the vitrification solution. Notes the shrunken
blastocyst in the vitrification solution (a) and
reexpanding blastocyst (b) upon warming.
Figure 2. Morphology of blastocyst in the vitrification solution (a) and warming solution (b)
(Ita Fauzia, 2014, Inverted Microscope, 320X, Zeiss)
These following Table 1. is presenting the data
of the outcome of blastocyst vitrification using Gama
Sleeved cryoloop as well as data of blastocyst
cryopreservation using loop produced by Hampton
ResearchÒ.
Blastocyst vitrification
Procedure of vitrification was done in room
temperature (25-26°C). Blastocyst were exposing in
the equilibrium solution (7.5% EG (v/v); 7.5% DMSO
(v/v)) for 2-3 minutes, then transferred to the
vitrification solution (15% EG (v/v); 15% DMSO v/v;
10 mg/ml Ficoll; 0.65 M Sucrosa) for 30 seconds.6
Blastocyst then inserted on to the loop of Gama
Sleeved cryoloop before directly plunging into the
liquid nitrogen.
Blastocyst warming
Following FET program, on the day of embryo
transfer embryos were warmed rapidly by two
step technique in 0.25M and 0.125M sucrosa, for 2
and 3 minutes subsequently6. Embryos were then
cultured in the culture media untill needed.
Recovered embryos were assessed for integrity
of each blastomere or reexpand of blastocoele of
the blastocyst. The embryos were cultured and 1
or 2 embryos with d” 25% lysis blastomere were
transferred to each recipient woman. Lutheal
support of 8% vaginal gel progesteron were given
for 14 days until pregnancy test done. Clinical
pregnancy was determined by fetal heart motion
assessed by ultrasound on 5 week after embryo
transfer.
RESULT AND DISCUSSION
This study describes data of the preliminary
outcome of blastocyst vitrification program using
0.1µl Gama Sleeved cryoloop in our ART laboratory.
Previous data reported by Desai et al, 2013 was as
comparation to this present study.
A total of 97 blastocysts were vitrified and
warmed from 67 patients. Ninety one blastocysts
survived (93.8%) after warming. A total of 91 blastocysts
were transferred into 66 patients. In one case, no
blastocysts survived after vitrification and warming.
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Table 1. Vitrification outcome for blastocyst stage embryos using cryoloop
(Gama Sleeved  cryoloop and Hampton ResearchÒ cryoloop)
Of 66 transfers, 29 women conceived (43.9%).
Currently, 23 baby born of 20 deliveries while another
5 ongoing pregnancies. There was 1 early pregnancy
loss, 2 miscarriages at 12 weeks pregnancy, and one
infant died due to a congenital anomaly. Quite similar
with the data reported by Desai et al., 2013, of 85
transfer cycles, 39 women conceived (46%). Twenty
six deliveries was reported with 7% misscariages.
Vitrification would be a preferred method of
cryopreservation to the slow-cooling method
because of the lack of ice crystal formation. In a
previous data using mouse model, we reported data
of vitrification method using 0.1µl Gama Sleeved
cryoloop for vitrification of 8 cell to blastocyst stage
embryo. The device of 0.1µl Gama Sleeved cryoloop
accomodated viability of preserved embryos
assessed by post warming embryogenesis and
mitochondria activity.15
The success of vitrification procedures has
recently been increased by techniques that
substantially reduce the volume of vitrification
solution. Among such techniques, the cryoloop must
be a most refined strategy.17,18  The loop seems
accomodate very well the cooling and warming rate.
Furthermore, the technique using the cryoloop is
easier and simpler to be applied in our own clinic.
Refinement of culture media, based upon the
physiology of the developing embryos in the human
reproductive tract, it is now possible to grow viable
blastocysts in vitro. This present data of human
blastocyst, high survival rate may be resulted from
prevented intracellular ice formation by slowly
dehydrated and concentrated in the process of
blastocyst vitrification16. This study used loop as
model in the case of human setting in which the
number of embryos vitrified is limited. One single
human embryo of the patient will be invaluable to
be sustained its vaibility through the whole
procedure of vitrification and storage, thus optimally
preserved the fertility of the patients.15
In our clinic, certain group of patients will have
an opportunity to have blastocyst. Because of the
resulting high implantation rates, blastocyst transfer
will be a reliable approach in ART. Single blastocyst
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transfer, involved in numbers of good grade
blastocyst that not transferred for the fresh cycle. In
this present study, we reported that vitrification using
the 0.1µl Gama Sleeved cryoloop is a clinically useful
method for the cryopreservation of human
blastocysts. However, further study will be needed
to yield an optimal outcome and thus lead the best
use of valuable embryos.
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